RESMED INC — Director's Dealing 2017

Dec 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-12-05

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-05	ResMed Common Stock	G	1184	$84.46	Disposed	110063	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	42627	Direct

Footnotes

F1: Represents a gift of shares to the Douglas Family Fund-Giving charitable account. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares.

F2: The price reported above represents the average of the high and low trading price on the day of the transaction.

F3: Includes transfer of 19,879 shares between the direct holdings and the Douglas Family Trust indirect holdings on 11/29/2017.